DrugPatentWatch Database Preview
Emcure Pharms Ltd Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?
EMCURE PHARMS LTD has twenty-nine approved drugs.
There is one tentative approval on EMCURE PHARMS LTD drugs.
Summary for Emcure Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 26 |
| Ingredients: | 26 |
| NDAs: | 29 |
Drugs and US Patents for Emcure Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emcure Pharms Ltd | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 202359-001 | Sep 28, 2012 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Emcure Pharms Ltd | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | fosinopril sodium; hydrochlorothiazide | TABLET;ORAL | 079025-001 | Sep 17, 2010 | DISCN | No | No | Start Trial | Start Trial | |||||
| Emcure Pharms Ltd | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 201783-001 | Mar 12, 2013 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
